Food

Power AI real-world monitoring ensures the safe and efficient progress of the expansion of China's longest expressway

TURFAN,China,Nov. 18,2024-- On November 15,in the transmission safety monitoring center of the State Grid Turfan Power Supply Company,the power supply personnel used the AI real-world monitoring devic

SMU Leads Singapore-Indonesia Educational Collaboration Through RI-SING University Network

SINGAPORE,Nov. 18,2024--The Singapore Management University(SMU) hosted the third RI-SING University Network (RUN) meeting on 12-13 November 2024,bringing together top educational leaders from Singap

AV-Comparatives Releases 2024 Advanced Threat Protection Test Results for Enterprise Cybersecurity Solutions

Helping CISOs Select Top-Performing Cybersecurity Solutions with Rigorous Advanced Threat Protection Testing Results for 2024

WELLlife COVID-19/Influenza A&B Home Test on Sale for Black Friday and Cyber Monday

BOLINGBROOK,Ill.,Nov. 18,2024--Stock up your family\'s medicine cabinet this Black Friday and Cyber Monday. WELLlife,a leading innovator in medical diagnostic and testing solutions,is increasing acces

Two-Day Countdown - Hong Kong Fashion Fest kicks off a city-wide celebration of fashion, culture and creativity

HONG KONG,Nov. 19,2024-- The highly anticipated Hong Kong FashionFest,running from 20 November to 4 December 2024,is set to take over the city with an expansive programme celebrating fashion,creativi

Telix to Add FAP-Targeting Candidates to Theranostic Pipeline

MELBOURNE,Australia,Nov. 19,2024-- Telix Pharmaceuticals Limited (ASX: TLX; Nasdaq: TLX,Telix,the Company) today announces it will expand its theranostic pipeline with new assets targeting Fibroblast

FinVolution Group Reports Third Quarter 2024 Unaudited Financial Results

-Third Quarter Total Transaction Volume reached RMB52.2 billion,up 1.8% year-over-year- -Third Quarter International Transaction Volume reached RMB2.7 billion,up 22.7% year-over-year-

Celltrion presents additional data from phase III randomized controlled trials to further support biosimilarity for CT-41 (biosimilar candidate of denosumab) and CT-P47 (biosimilar candidate of tocilizumab) at American College of Rheumatology (ACR) Conver

78-Week results from Phase III randomized controlled trial (RCT) including switching data from reference denosumab to CT-P41 (biosimilar candidate of denosumab) demonstrate comparable efficacy and sa

G20's focus on development highlights the contributions of the 'Global South': Global Times editorial

BEIJING,Nov. 19,2024-- The 19th G20 Summit is being held in Rio de Janeiro,Brazil,from November 18 to 19. Chinese PresidentXi Jinping said at the summit that China has announced the decision to give a

GHIT Fund Awarded Open Philanthropy Grant to Expand Funding Sources for Global Health R&D

TOKYO,Nov. 19,2024--The Global Health Innovative Technology (GHIT) Fundis pleased to announce that Open Philanthropy,a grantmaking organization based in San Francisco,California,has awarded funding fo

Home Previous 37 38 39 40 41 42 43 Next Tail

10 Items Per Page (Page 40 / 63) Total 621 Items